Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial-Reference-Cited by-同舟云学术

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial

Published:2021 Issue:1 Volume:32 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Motohashi Takashi¹^ORCID,Yabuno Akira²^ORCID,Michimae Hiroshi³^ORCID,Ohishi Tetsuro⁴^ORCID,Nonaka Miwa⁵^ORCID,Takano Masashi⁶^ORCID,Nishio Shin⁷^ORCID,Fujiwara Hiroyuki⁸^ORCID,Fujiwara Keiichi²^ORCID,Kondo Eiji⁹^ORCID,Sugiyama Toru¹⁰^ORCID,Tabata Tsutomu¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan.

2. Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Tokyo, Japan.

3. Kitasato University School of Pharmacy, Tokyo, Japan.

4. Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan.

5. Global Clinical Research Coordinating Center Division of Clinical Research Kitasato University Hospital, Tokyo, Japan.

6. Department of Clinical Oncology, National Defense Medical College Hospital, Tokorozawa, Japan.

7. Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.

8. Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan.

9. Department of Obstetrics and Gynecology, Mie University School of Medicine, Mie, Japan.

10. Department of Obstetrics and Gynecology, St. Mary's Hospital, Kurume, Japan.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2021.32.e9

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting;Pharmaceuticals;2023-05-29

2. Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer;Cancer Medicine;2023-05-15

3. Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin;Supportive Care in Cancer;2023-04-19

4. Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer;Anticancer Research;2022-05-31

5. Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis;BMC Cancer;2022-02-16